封面
市場調查報告書
商品編碼
2107776

血脂分析儀市場:按應用、類型、最終用戶和地區分類

Lipid Analysis Devices Market, By Application, By Type, By End Users, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 258 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,血脂分析儀市場規模將達92億美元,到2033年將達到118億美元。預計2026年至2033年,該市場將以6.1%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 92億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 6.10% 2033年市場規模預測: 118億美元

醫療機構日益重視預防醫學、心血管疾病管理和精準診斷檢測,推動了血脂分析儀市場的成長。血脂分析儀能夠幫助臨床醫生快速測量膽固醇、三酸甘油酯和其他血脂指標,從而實現代謝性疾病和心血管疾病的早期診斷和有效管理。文明病率的上升、人們對定期健康監測意識的增強以及診斷技術的不斷進步,都在推動全球醫院、實驗室、診所和研究機構對血脂分析儀的廣泛應用。

製造商正透過推出具備數位化連接功能的先進系統來拓展血脂分析儀市場,這些系統能夠帶來更高的準確性、更快的檢測速度和更佳的臨床決策支援。醫療機構正日益採用即時檢測解決方案、攜帶式診斷設備和自動化檢測平台,以提高效率和可近性。醫療保健領域的投資增加、技術進步以及個人化醫療的日益普及,正進一步加速市場發展。此外,各公司也積極應對人口老化所帶來的挑戰,並加強疾病預防工作,進而在全球市場創造新的成長機會。

市場動態

醫療保健機構正透過優先考慮心血管和代謝疾病的早期診斷、預防醫學和有效管理,加速推動血脂分析儀市場的成長。高膽固醇、肥胖、糖尿病和其他文明病的日益普遍,推動了對可靠血脂檢測解決方案的需求。製造商正在開發自動化分析儀和攜帶式分析儀等診斷技術,以提高準確性、效率和便利性。這些進步正在推動全球醫院、實驗室、診所和研究機構採用先進的血脂分析系統。

為了滿足不斷變化的醫療保健需求,製造商們正在推出靈敏度更高、具備數位化連接功能且操作簡便的創新血脂分析儀。由於即時檢測解決方案能夠快速提供檢測結果,從而加快臨床決策,因此其在醫療專業人員中的應用正在迅速擴展。儘管這些解決方案具有諸多優勢,但高成本、維護費用高以及在發展中地區供應有限仍然是市場擴張面臨的挑戰。各公司正努力透過開發價格合理的解決方案、加強分銷管道以及投資普及的診斷技術來克服這些挑戰。

大型診斷公司和新興市場參與企業正積極透過部署先進的脂質分析解決方案和拓展全球企業發展來重塑競爭格局。這些公司正透過建立策略聯盟、推出新產品和進行研究來提陞技術能力並鞏固市場地位。對個人化醫療日益成長的需求、不斷上漲的醫療成本以及數位健康技術的廣泛應用,都創造了巨大的成長機會。隨著醫療系統持續重視預防性診斷,市場參與企業正透過瞄準新興市場來加速創新並拓展業務。

本次調查的主要特點

  • 該研究重點介紹了各個細分市場的潛在商機,並為相關人員提供了一個有吸引力的投資提案矩陣。
  • 本研究深入分析了市場促進因素、限制因素、機會、新興技術、產品創新、市場趨勢、區域展望以及主要市場參與企業採取的競爭策略。
  • 本研究根據公司簡介、產品系列、近期發展、財務績效和策略舉措,對脂質分析儀市場的主要參與者進行了分析。
  • 透過利用本報告中的見解,行銷負責人、高階主管和經營團隊將能夠就未來的產品開發、技術採用、市場擴張、策略聯盟和商業化策略做出明智的決策。
  • 《血脂分析儀市場》報告的目標受眾廣泛,包括投資者、診斷設備製造商、醫療保健提供者、醫院、臨床實驗室、分銷商、技術開發商、研究機構、新市場參與企業和金融相關人員。
  • 相關人員可以透過「血脂分析儀市場」報告中提出的分析框架、競爭基準和市場估值矩陣做出明智的策略決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 影響分析
  • 市場趨勢
  • 主要進展
  • 產品核准
  • 合作關係、併購
  • 監理情勢
  • PEST分析
  • 波特五力分析
  • 流行病學
  • 穩健的管道分析

第4章 全球血脂分析儀市場:依應用領域分類,2021-2033年

  • 高血脂症
  • 高三酸甘油脂血症
  • 遺傳性高膽固醇症
  • 高脂蛋白血症
  • 唐吉爾氏症

第5章 全球血脂分析儀市場:依類型分類,2021-2033年

  • 臨床分析儀
  • 即時檢測設備

第6章 全球血脂分析儀市場:依最終用戶分類,2021-2033年

  • 醫院
  • 診斷診所
  • 居家照護環境

第7章 全球血脂分析儀市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第8章 競爭情勢

  • 熱圖分析
  • 市佔率分析
  • 公司簡介
    • Polymer Technology Systems, Inc.
    • Jant Pharmacal Corporation
    • Alere
    • F. Hoffmann-La Roche Ltd.
    • Acon Laboratories, Inc.
    • Cholestech Corporation
  • 分析師意見

第9章

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI1488

Lipid Analysis Devices Market is estimated to be valued at USD 9.2 Bn in 2026 and is expected to reach USD 11.8 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.1% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 9.2 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.10% 2033 Value Projection: USD 11.8 Bn

Healthcare providers are driving the growth of the Lipid Analysis Devices market as they increasingly emphasize preventive healthcare, cardiovascular disease management, and precise diagnostic testing. Lipid analysis devices help clinicians quickly measure cholesterol, triglycerides, and other lipid parameters, enabling early diagnosis and effective management of metabolic and cardiovascular conditions. The rising incidence of lifestyle-related diseases, growing awareness of routine health monitoring, and continuous advancements in diagnostic technologies are encouraging hospitals, laboratories, clinics, and research institutions to adopt lipid analysis devices worldwide.

Manufacturers are expanding the Lipid Analysis Devices market by introducing advanced systems that deliver higher accuracy, faster results, and digital connectivity for improved clinical decision-making. Healthcare organizations are increasingly adopting point-of-care testing solutions, portable diagnostic devices, and automated laboratory platforms to enhance efficiency and accessibility. Rising healthcare investments, technological advancements, and the growing use of personalized medicine are further accelerating market development. Additionally, companies are addressing the needs of an aging population and increasing disease prevention initiatives, creating new growth opportunities across global markets.

Market Dynamics

Healthcare providers are accelerating the growth of the Lipid Analysis Devices market by prioritizing early diagnosis, preventive healthcare, and effective management of cardiovascular and metabolic diseases. The increasing incidence of high cholesterol, obesity, diabetes, and other lifestyle-related disorders is driving demand for reliable lipid testing solutions. Manufacturers are advancing diagnostic technologies, including automated analyzers and portable testing devices, to improve accuracy, efficiency, and convenience. These developments are encouraging hospitals, laboratories, clinics, and research institutions to adopt advanced lipid analysis systems worldwide.

Manufacturers are introducing innovative lipid analysis devices with improved sensitivity, digital connectivity, and user-friendly features to address changing healthcare needs. Healthcare professionals are increasingly using point-of-care testing solutions because they deliver rapid results and enable faster clinical decision-making. Despite these advantages, high equipment costs, maintenance expenses, and limited availability in developing regions continue to challenge market expansion. Companies are overcoming these barriers by developing affordable solutions, strengthening distribution channels, and investing in accessible diagnostic technologies.

Leading diagnostic companies and emerging market players are actively shaping the competitive landscape by launching advanced lipid analysis solutions and expanding their global reach. Companies are forming strategic partnerships, introducing new products, and conducting research activities to enhance technological capabilities and strengthen market positions. Rising demand for personalized healthcare, increased healthcare spending, and greater adoption of digital health technologies are creating significant growth opportunities. As healthcare systems continue to emphasize preventive diagnostics, market participants are accelerating innovation and targeting emerging markets for expansion.

Key Features of the Study

  • It highlights potential revenue opportunities across various market segments and presents attractive investment proposition matrices for stakeholders.
  • This study provides key insights into market drivers, restraints, opportunities, emerging technologies, product innovations, market trends, regional outlook, and competitive strategies adopted by leading market participants.
  • It profiles key players in the Lipid Analysis Devices Market based on company overview, product portfolio, recent developments, financial performance, and strategic initiatives.
  • Key companies covered as part of this study include Polymer Technology Systems, Inc., Jant Pharmacal Corporation, Alere, F. Hoffmann-La Roche Ltd., Acon Laboratories, Inc., and Cholestech Corporation.
  • Insights from this report enable marketers, business executives, and management teams to make informed decisions regarding future product development, technology adoption, market expansion, strategic partnerships, and commercialization strategies.
  • The Lipid Analysis Devices Market report serves a wide range of stakeholders, including investors, diagnostic device manufacturers, healthcare providers, hospitals, clinical laboratories, distributors, technology developers, research organizations, new market entrants, and financial analysts.
  • Stakeholders can make well-informed strategic decisions through the analytical frameworks, competitive benchmarking, and market assessment matrices presented in the Lipid Analysis Devices Market report.

Market Segmentation

  • By Application (Revenue, USD Bn, 2021-2033)
  • Hyperlipidemia
  • Hypertriglyceridemia
  • Familial Hypercholesterolemia
  • Hyperlipoproteinemia
  • Tangier Disease
  • By Type (Revenue, USD Bn, 2021-2033)
  • Clinical Analyzer
  • Point-of-care devices
  • By End Users (Revenue, USD Bn, 2021-2033)
  • Hospitals
  • Diagnostic clinics
  • Homecare settings
  • By Region (Revenue, USD Bn, 2021-2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Key Players
  • Polymer Technology Systems, Inc.
  • Jant Pharmacal Corporation
  • Alere
  • Hoffmann-La Roche Ltd.
  • Acon Laboratories, Inc.
  • Cholestech Corporation.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Application
    • Market Snapshot, By Type
    • Market Snapshot, By End Users
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Product Approval
  • Collaboration/Merge/Acquisition
  • Regulatory Landscape
  • PEST Analysis
  • Porter's Five Forces Analysis
  • Epidemiology
  • Robust Pipeline Analysis

4. Global Lipid Analysis Devices Market, By Application, 2021 - 2033, (USD Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022- 2033
    • Segment Trends
  • Hyperlipidemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Hypertriglyceridemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Familial Hypercholesterolemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Hyperlipoproteinemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Tangier Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

5. Global Lipid Analysis Devices Market, By Type, 2021 - 2033, (USD Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Clinical Analyzer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Point-of-care devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Global Lipid Analysis Devices Market, By End Users, 2021 - 2033, (USD Billion)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Diagnostic clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
  • Homecare settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

7. Global Lipid Analysis Devices Market, By Region, 2021 - 2033, (USD Billion)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2022-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Billion)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profile
    • Polymer Technology Systems, Inc.
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Jant Pharmacal Corporation
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Alere
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • F. Hoffmann-La Roche Ltd.
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Acon Laboratories, Inc.
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
    • Cholestech Corporation
      • Company Highlights
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Market Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About Us